Description
Guide Select™ is a biochemical screening assay based on the ONE-seq™ platform that enables variant-aware, off-target risk assessment for multiple guide RNAs in parallel. Guide Select can de-risk early cell and gene therapy development through precise, high-sensitivity identification of potential off-target effects. This data-driven approach helps to optimize guide RNA selection and streamline the development process, saving time and resources.